Momenta Pharmaceuticals, Inc. (MNTA)

[marthambles]

As a very long term holder, I have to wonder whether it isn't time to cash in the chips. At this point, the potential for good news seems modest (possibly a partnership for FOB compounds, otherwise nothing probably until 2016). The big negative would be approval of a another copaxone generic.

While it seems unlikely, I remember how surprised many were when Amphastar's Lovenox was approved, and how ultimately it devastated the stock price.

How much more upside can their really be in the near future?